SCHEMBL8635142

SCHEMBL8635142

CN(C)CCNC(=O)c1c([N+](=O)[O-])ccc(N(CCCl)CCCl)c1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 2/20 0.43
GSTM2 P28161 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 2/20 0.40
POLB P06746 2/20 0.40
ALDH1A1 P00352 4/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPK1 P28482 1/20 0.38
HCAR3 P49019 1/20 0.36
CYP1A2 P05177 1/20 0.36
EGFR P00533 1/20 0.35
SRC P12931 1/20 0.35
HPGD P15428 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
LMNA P02545 1/20 0.34
HRH4 Q9H3N8 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL8760874 0.85 HCAR3 (0.39) SMN1; SMN2MAPTHTTPOLBALDH1A1
SCHEMBL8639690 0.80 SMN1; SMN2 (0.43) GSTP1GSTM2SMN1; SMN2MAPTHTT
SCHEMBL2977189 0.79 ALDH1A1 (0.37) MAPTPOLBALDH1A1NPSR1CYP1A2
SCHEMBL8635371 0.78 HCAR3 (0.39) SMN1; SMN2MAPTPOLBALDH1A1MAPK1
SCHEMBL2977058 0.77 GSTP1 (0.39) GSTP1GSTM2SMN1; SMN2MAPTHTT
SCHEMBL3423746 0.76 NSD2 (0.41) GSTP1GSTM2SMN1; SMN2MAPTPOLB
SCHEMBL7474447 0.76 SMN1; SMN2 (0.44) GSTP1GSTM2SMN1; SMN2MAPTHTT
SCHEMBL7476700 0.76 HTT (0.49) SMN1; SMN2MAPTHTTPOLBALDH1A1
SCHEMBL3585555 0.76 ALDH1A1 (0.36) POLBALDH1A1NPSR1HPGDLMNA
SCHEMBL2968993 0.76 PRMT5 (0.39) GSTP1GSTM2SMN1; SMN2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750782-A ANTICARCINOGENIC AGENTS, ANTIHYPOXIC AGENTS, PRODRUGS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1998-05-12 US disclosed
US-5739376-A Fullerene derivatives, methods of preparing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1998-04-14 US disclosed
EP-0616609-B1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS CANCER RES CAMPAIGN TECH (GB) 1997-06-18 EP disclosed
US-5571845-A Nitroaniline derivatives and their use as anti-tumour agents CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-11-05 US disclosed
EP-0616609-A1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS. CANCER RES CAMPAIGN TECH (GB) 1994-09-28 EP disclosed
WO-1993011099-A1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1993-06-10 WO disclosed